by Lily Yang | Aug 31, 2021 | blepharitis, blepharitis symptoms, computer vision syndrome, dry eye relief, Eye infection, Meibomian Gland Dysfunction (MGD)
Looking for natural cures for dry eyes. TheraLife has the complete solution. Oral treatment that restore and revives. No more drops.
by Lily Yang | Aug 29, 2021 | computer vision syndrome, contact lenses, dry eye disease, dry eye relief, dry eye symptoms, dry eye treatment, eye drops, LASIK, Meibomian Gland Dysfunction (MGD), Rheumatoid Arthritis, Sjogren's Syndrome, Sjopgren's, tests for dry eyes
Learn how to diagnose and treat dry eyes. TheraLife treats dry eyes orally from inside out. No more drops.
by Lily Yang | Aug 6, 2021 | computer vision syndrome, dry eye relief, dry eye treatment, dry eyes at night, eye drops, eye health, Meibomian Gland Dysfunction (MGD)
Gest dry eye treatment that works – TheraLIfe. No more drops.
by Lily Yang | Jun 30, 2021 | blepharitis, computer vision syndrome, dry eye disease, dry eye treatment, glaucoma, Hashimoto's Thyroiditis, Sjogren's Syndrome, tests for dry eyes
Glaucoma drops result in dry eyes. Get complete recovery with TheraLife now.
by Lily Yang | Jun 16, 2021 | autoimmune, computer vision syndrome, dry eye disease, dry eye relief, dry eye symptoms, dry eye treatment, Uveitis
Eyes light sensitive? – Get Help from TheraLife Light sensitivity is a hall mark of chronic dry eyes. Treat your dry eyes to get rid of light sensitivity. How do dry eyes cause light sensitivity? Dry eye syndrome makes the cornea more sensitive to light. In... 
by Lily Yang | May 30, 2021 | autoimmune, blepharitis, computer vision syndrome, dry eye disease, dry eye symptoms, dry eye treatment, eye drops, LASIK, Meibomian Gland Dysfunction (MGD), Ocular Rosacea, Sjogren's Syndrome
Currently, there is no permanent cure for dry eye syndrome. However, dry eye treatments can help you maintain moisture in the eyes, reduce symptoms and protect vision. Dry eye syndrome is a common condition where the eyes cannot produce tears, eyelids become infected... 
